These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17997275)

  • 61. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
    Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
    Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 63. SPI1 defective mutants of Salmonella enterica induce cross-protective immunity in chickens against challenge with serovars Typhimurium and Enteritidis.
    Matulova M; Havlickova H; Sisak F; Babak V; Rychlik I
    Vaccine; 2013 Jun; 31(31):3156-62. PubMed ID: 23684831
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Insertion of a 59 amino acid peptide in Salmonella Typhimurium membrane results in loss of virulence in mice.
    Porta A; Morello S; Granata I; Iannone R; Maresca B
    FEBS J; 2014 Nov; 281(22):5043-53. PubMed ID: 25208333
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Salmonella DIVA vaccine reduces disease, colonization and shedding due to virulent S. Typhimurium infection in swine.
    Bearson BL; Bearson SMD; Brunelle BW; Bayles DO; Lee IS; Kich JD
    J Med Microbiol; 2017 May; 66(5):651-661. PubMed ID: 28516860
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reversible synthesis of colanic acid and O-antigen polysaccharides in Salmonella Typhimurium enhances induction of cross-immune responses and provides protection against heterologous Salmonella challenge.
    Li P; Liu Q; Huang C; Zhao X; Roland KL; Kong Q
    Vaccine; 2017 May; 35(21):2862-2869. PubMed ID: 28412074
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection.
    Yrlid U; Svensson M; Håkansson A; Chambers BJ; Ljunggren HG; Wick MJ
    Infect Immun; 2001 Sep; 69(9):5726-35. PubMed ID: 11500449
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regulated delayed attenuation enhances the immunogenicity and protection provided by recombinant Salmonellaenterica serovar Typhimurium vaccines expressing serovar Choleraesuis O-polysaccharides.
    Zhao X; Liang S; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Yang Q; Wu Y; Zhang S; Zhang L; Liu Y; Yu Y; Cheng A
    Vaccine; 2018 Aug; 36(33):5010-5019. PubMed ID: 30017143
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Extragenic suppressors of growth defects in msbB Salmonella.
    Murray SR; Bermudes D; de Felipe KS; Low KB
    J Bacteriol; 2001 Oct; 183(19):5554-61. PubMed ID: 11544217
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection.
    Xu C; Zhang BZ; Lin Q; Deng J; Yu B; Arya S; Yuen KY; Huang JD
    BMC Infect Dis; 2018 Apr; 18(1):195. PubMed ID: 29699491
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.
    Han YW; Kim SB; Rahman M; Uyangaa E; Lee BM; Kim JH; Park KI; Hong JT; Han SB; Eo SK
    Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):335-45. PubMed ID: 21543119
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA.
    Li Y; Wang S; Scarpellini G; Gunn B; Xin W; Wanda SY; Roland KL; Curtiss R
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):593-8. PubMed ID: 19114649
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis.
    Rossi O; Caboni M; Negrea A; Necchi F; Alfini R; Micoli F; Saul A; MacLennan CA; Rondini S; Gerke C
    Clin Vaccine Immunol; 2016 Apr; 23(4):304-14. PubMed ID: 26865597
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunization of pigs to prevent disease in humans: construction and protective efficacy of a Salmonella enterica serovar Typhimurium live negative-marker vaccine.
    Selke M; Meens J; Springer S; Frank R; Gerlach GF
    Infect Immun; 2007 May; 75(5):2476-83. PubMed ID: 17296750
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Further characterization of a highly attenuated Yersinia pestis CO92 mutant deleted for the genes encoding Braun lipoprotein and plasminogen activator protease in murine alveolar and primary human macrophages.
    van Lier CJ; Tiner BL; Chauhan S; Motin VL; Fitts EC; Huante MB; Endsley JJ; Ponnusamy D; Sha J; Chopra AK
    Microb Pathog; 2015 Mar; 80():27-38. PubMed ID: 25697665
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Regulated Delayed
    Su H; Liu Q; Wang S; Curtiss R; Kong Q
    Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
    [No Abstract]   [Full Text] [Related]  

  • 77. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.
    Sha J; Agar SL; Baze WB; Olano JP; Fadl AA; Erova TE; Wang S; Foltz SM; Suarez G; Motin VL; Chauhan S; Klimpel GR; Peterson JW; Chopra AK
    Infect Immun; 2008 Apr; 76(4):1390-409. PubMed ID: 18227160
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of a live attenuated Salmonella enterica serovar Typhimurium vaccine on farrow-to-finish pig farms.
    De Ridder L; Maes D; Dewulf J; Butaye P; Pasmans F; Boyen F; Haesebrouck F; Van der Stede Y
    Vet J; 2014 Nov; 202(2):303-8. PubMed ID: 25278382
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Distinct innate responses are induced by attenuated Salmonella enterica serovar Typhimurium mutants.
    Powell DA; Roberts LM; Ledvina HE; Sempowski GD; Curtiss R; Frelinger JA
    Cell Immunol; 2016 Jan; 299():42-9. PubMed ID: 26546408
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunosuppression and nitric oxide production induced by parenteral live Salmonella vaccines do not correlate with protective capacity: a phoP::Tn10 mutant does not suppress but does protect.
    Eisenstein TK; Meissler JJ; Miller SI; Stocker BA
    Vaccine; 1998 Jan; 16(1):24-32. PubMed ID: 9607005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.